GT200000009A - Uso de pirazol-carboxamidas. - Google Patents

Uso de pirazol-carboxamidas.

Info

Publication number
GT200000009A
GT200000009A GT200000009A GT200000009A GT200000009A GT 200000009 A GT200000009 A GT 200000009A GT 200000009 A GT200000009 A GT 200000009A GT 200000009 A GT200000009 A GT 200000009A GT 200000009 A GT200000009 A GT 200000009A
Authority
GT
Guatemala
Prior art keywords
carboxamids
pirazol
new
well
pirazolcarboxilic
Prior art date
Application number
GT200000009A
Other languages
English (en)
Inventor
Jurgen Stoltefuss
Gabriele Braunlich
Berthold Hinzen
Thomas Studemann
Thomas Kramer
Michael Sperzel
Ulrich Nielsch
Martin Bechem
Josef Pernerstorfer
Emanuel Lohrmann
Christoph Gerdes
Klemens Lustig
Lorenz Mayr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT200000009A publication Critical patent/GT200000009A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A PIRAZOLCARBOXAMIDAS NUEVAS Y CONOCIDAS DE FORMULAS GENERALES (I & II). ADEMAS SE DESCRIBE LA PREPARACION DE LAS PIRAZOLCARBOXAMIDAS O BIEN MEDIANTE QUIMICA EN FASE SOLIDA O BIEN A TRAVES DE LOS NUEVOS ACIDOS PIRAZOLCARBOXILICOS.
GT200000009A 1999-02-04 2000-02-03 Uso de pirazol-carboxamidas. GT200000009A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19904397A DE19904397A1 (de) 1999-02-04 1999-02-04 Verwendung von Pyrazol-Carbonsäureamiden

Publications (1)

Publication Number Publication Date
GT200000009A true GT200000009A (es) 2001-07-27

Family

ID=7896339

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200000009A GT200000009A (es) 1999-02-04 2000-02-03 Uso de pirazol-carboxamidas.

Country Status (8)

Country Link
EP (1) EP1148879A2 (es)
JP (1) JP2002536348A (es)
AR (1) AR022470A1 (es)
AU (1) AU3150300A (es)
CA (1) CA2361636A1 (es)
DE (1) DE19904397A1 (es)
GT (1) GT200000009A (es)
WO (1) WO2000045894A2 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6878729B2 (en) 2001-05-04 2005-04-12 The Procter & Gamble Company Medicinal uses of dihydropyrazoles
US8710038B2 (en) 2004-09-17 2014-04-29 Exelixis, Inc. Pyrazole kinase modulators and methods of use
UY30892A1 (es) 2007-02-07 2008-09-02 Smithkline Beckman Corp Inhibidores de la actividad akt
EA018907B1 (ru) 2009-01-30 2013-11-29 ГЛЭКСОСМИТКЛАЙН ЭлЭлСи Кристаллический гидрохлорид n-{(1s)-2-амино-1-[(3-фторфенил)метил]этил}-5-хлор-4-(4-хлор-1-метил-1h-пиразол-5-ил)-2-тиофенкарбоксамида
EP4173485A1 (en) * 2021-10-27 2023-05-03 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Protein aggregation inhibiting compounds for plant disease control

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH27357A (en) * 1989-09-22 1993-06-21 Fujisawa Pharmaceutical Co Pyrazole derivatives and pharmaceutical compositions comprising the same
US5434178A (en) * 1993-11-30 1995-07-18 G.D. Searle & Co. 1,3,5 trisubstituted pyrazole compounds for treatment of inflammation
WO1997019039A1 (en) * 1995-11-17 1997-05-29 Novartis Ag Solid phase synthesis of heterocyclic compounds and combinatorial compound library
DE19904396A1 (de) * 1999-02-04 2000-08-10 Bayer Ag Substituierte Pyrazolbenzylamin-Derivate
DE19904406A1 (de) * 1999-02-04 2000-08-10 Bayer Ag Substituierte Pyrazolcarbonsäuren

Also Published As

Publication number Publication date
AU3150300A (en) 2000-08-25
WO2000045894A2 (de) 2000-08-10
JP2002536348A (ja) 2002-10-29
DE19904397A1 (de) 2000-08-10
WO2000045894A3 (de) 2001-04-19
EP1148879A2 (de) 2001-10-31
AR022470A1 (es) 2002-09-04
CA2361636A1 (en) 2000-08-10

Similar Documents

Publication Publication Date Title
HN2001000027A (es) Derivados de purina
BR0111639A (pt) Uso de uma molécula de ácido oligodeoxinucléico, e composição farmacêutica contendo a mesma
BR0314354A (pt) Formação para gentes lipofìlicos
HN2002000300A (es) Nuevos derivados de piperazina
IL150756A0 (en) Novel use of hiv proteins
ES2194231T3 (es) Una nueva forma de compuesto.
HN1998000036A (es) Compuesto de pirazina
GT200400242A (es) Uso extendido de combinacion que comprende estrogenos y progestina.
BR9803596A (pt) Derivados do resorcinol.
BR0111358A (pt) Compostos de tioacetamida e seu uso
DE60143984D1 (de) Neue phenylalanin-derivate
CY1112139T1 (el) Μια φαρμακευτικη συνθεση περιλαμβανουσα κρυσταλλικη ριτοναβιρη μορφη ιι και ενα παρασκευασμα εξ αυτης
FI20011578A0 (fi) Menetelmä puhtaan sitalopraamin valmistamiseksi
ATE279114T1 (de) Dermal applizierbare wasserhaltige formulierungen von parasitiziden
SE9901077D0 (sv) Novel use
HN2001000235A (es) Derivados puentes de piperazina
BR0114379A (pt) Derivados de c-ciclohexilmetilamina substituìdos
BR9813810B1 (pt) surfactante baseado em um orto éster, a sua preparação e o seu uso.
DE60132362D1 (de) Herstellung von ultradünnwandigen cordierit-strukturen
GT200000009A (es) Uso de pirazol-carboxamidas.
DE60142051D1 (de) Herstellung von perfluorolefinen
BR0114380A (pt) Derivados-1-aminobutan-3-ol-substituìdos
DE69921486D1 (de) Dextran-leptin konjugate, pharmazeutische zusammentsetzungen und verbundene verfahren
DK0536197T3 (da) Ren, krystallinsk form af rifapentine
HN2001000021A (es) Nuevos derivados de amidas heterociclicas